Abstract
Objective: During the early part of the COVID-19 pandemic, non-pharmacologic interventions were the strategies for the prevention of severe acute respiratory syndrome coronavirus 2. The Ministry of Ayush, Govt. of India, had advised Arsenicum album 30C as a prophylactic to prevent COVID-19. This study was undertaken to evaluate the protective efficacy and safety of the Arsenicum album 30C. Methods: We conducted a prospective, multicenter, cluster-randomized, parallel-arm, community-based, open-label study involving apparently healthy individuals residing in containment areas of 7 cities in India. Clusters are defined as the population residing in the containment areas, who are under restriction for movement. Forty-two clusters were randomly assigned at 2:1 to the Arsenicum album 30C group (30 clusters) or to the control group (12 clusters, which received no specific therapy). The medicine was given twice daily for 7 days. The primary outcome was the incidence of COVID-19, as per the case definition notified by the National Centre for Disease Control, Government of India, during 3-week follow-up period. Results: The analysis included 32,186 individuals residing in 42 clusters (containment areas). A total of 22,693 individuals from 30 clusters received Arsenicum album 30C, and 9,493 individuals from 12 clusters were observed in the control group. The overall protective effect of the Arsenicum album 30C was 80.22% (95% confidence interval [CI], 71.16–86.44; 40 cases per 22,693 [6.04 per 10,000 person-weeks] in the Arsenicum album 30C group vs. 84 cases per 9,493 [29.78 per 10,000 person-weeks] in the control group). The protective effect of the Arsenicum album 30C against laboratory-confirmed COVID-19 was 68.22% (95% [CI], 49.64–80; 32 cases per 22,693 [4.83 per 10,000 person-weeks] in the Arsenicum album 30C group vs. 42 cases per 9,493 [14.93 per 10,000 person-weeks] in the control group). Adverse effects observed in both groups were mild and resolved without medication and sequelae. Conclusion: Homeopathic medicine Arsenicum album 30C was associated with a decrease in the incidence and provided some protection against COVID-19 as compared to nontreatment. Further randomized, double-blind, placebo-controlled trials may be conducted to validate the results of this study.
Journal Section:
Research Article / Originalarbeit
References
1.
World Health Organization
. WHO Director-General’s opening remarks at the media briefing on COVID-19: 11 March 2020 [Internet]
2020
[cited 2022 Jan 11]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.2.
Ministry of Health and Family Welfare
. COVID-19 statewise status [Internet]
2022
[cited 2022 Feb 4]. Available from: https://www.mohfw.gov.in/.3.
Thacker
T
. Coronavirus prevalence was up to 55% in containment zones: Sero survey [Internet]
, The Economic Times. 2020
[cited 2022 Feb 6]. Available from: https://m.economictimes.com/industry/healthcare/biotech/healthcare/virus-prevalence-was-up-to-55-in-containment-zones-sero-survey/articleshow/78223186.cms.4.
Sharma
N
, Sharma
P
, Basu
S
, Saxena
S
, Chawla
R
, Dushyant
K
The seroprevalence and trends of SARS-CoV-2 in Delhi, India: a repeated population-based seroepidemiological study
medRxiv
2020
.5.
Sharma
M
. One Covid-19 case led to 90. more infections: Govt analysis [Internet]
, India Today. 2020 [cited 2022 Jan 27]. Available from: https://www.indiatoday.in/coronavirus-outbreak/story/for-every-detected-covid-case-india-missed-90-infections-study-1750285-2020-12-17.6.
Thapar
K
. Why authorise a vaccine without phase 3 efficacy?” Gagandeep Kang [Internet]
, The Wire Science. 2022
[cited 2022 Jan 11]. Available from: https://science.thewire.in/health/watch-bharat-biotech-covaxin-astrazenca-covid-vaccine-gagandeep-kang/.7.
Dolgin
E
. COVID vaccine immunity is waning: how much does that matter
. Nature
. 2021 Sep 30
597
7878
606
7
.8.
Taylor
L
. Why scientists worldwide are watching UK COVID infections
. Nature
. 2021 Nov 11
599
7884
189
90
.9.
Mallapaty
S
. Europe’s COVID death toll could rise by hundreds of thousands
. Nature
. Epub ahead of print.10.
Basu
M
. Nearly half of new Covid cases over past week in Kerala are those fully vaccinated [Internet]
. The Print. 2021
[cited 2021 Dec 1]. Available from: https://theprint.in/health/nearly-half-of-new-covid-cases-over-past-week-in-kerala-are-those-fully-vaccinated/762382/.11.
Jacobs
J
. Homeopathic prevention and management of epidemic diseases
. Homeopathy
. 2018
;107
(3
):157
–60
.12.
Varanasi
R
, Nayak
D
. Homoeopathy in the management of infectious diseases: different facets of its use and implications for the future
. Indian J Res Homoeopathy
. 2020
;14
(2
):110
–21
.13.
Ministry of AYUSH, Government of India
. Advisory from Ministry of Ayush for meeting the challenge arising out of spread of Corona virus. Covid-19) in India [Internet]
2020
[cited 2022 Jan 27]. Available from: https://www.ayush.gov.in/docs/125.pdf%0Ahttps://health.ncog.gov.in/ayush-covid-dashbaord/assets/Classified/1.AYUSH-Against-COVID-19/a.14.
Hahnemann
S
Organon of medicine
5th and 6th edNew Delhi
B Jain Publishers (Pvt) Ltd
2004
. p. 267
.15.
Hox
JJ
, Moerbeek
M
, Kluytmans
A
, van de Schoot
R
. Analyzing indirect effects in cluster randomized trials. The effect of estimation method, number of groups and group sizes on accuracy and power
. Front Psychol
. 2014
;5
:78
.16.
Moberg
J
, Kramer
M
A brief history of the cluster randomized trial design [Internet]
The James Lind Library
2022
[cited 2022 June 11]. Available from: https://www.jameslindlibrary.org/articles/a-brief-history-of-the-cluster-randomized-trial-design/.17.
Ministry of Home Affairs, Government of India
. Guideline for containment area [Internet]
. Available from: https://www.mha.gov.in/sites/default/files/MHA-Order-Dt.1.5.2020-to-extend-Lockdown-period-for-2-weeks-w.e.f.4.5.2020-with-new-guidelines.pdf.18.
Ministry of Health and Family Welfare, Government of India
Homoeopathic pharmacopoiea of India
New Delhi
First edit.Govt. of India
1983
Vol. IV
. p. 136
7
.19.
National Center for Disease Control
. Revised case definition of Covid-19 (11.11.2020) [Internet]
2020
[cited 2022 Jan 11]. Available from: https://ncdc.gov.in/showfile.php?lid=611.20.
Ministry of Ayush
. Ayurveda’s immunity boosting measures for self care during. COVID 19 crisis [Internet]
2022
[cited 2022 Jan 11]. Available from: https://www.ayush.gov.in/docs/123.pdf.21.
Madaan
A
, Kanjilal
S
, Gupta
A
, Sastry
JL
, Verma
R
, Singh
ATJM
. Evaluation of immunostimulatory activity of Chyawanprash using in vitro assays
. Indian J Exp Biol
. 2015
;53
(3
):158
–63
.22.
Kumar
P
, Kamle
M
, Mahato
DK
, Bora
H
, Sharma
B
, Rasane
P
. Tinospora cordifolia (Giloy): phytochemistry, ethnopharmacology, clinical application and conservation strategies
. Curr Pharm Biotechnol
. 2020
;21
(12
):1165
–75
.23.
Bennett
S
, Parpia
T
, Hayes
R
, Cousens
S
. Methods for the analysis of incidence rates in cluster randomized trials
. Int J Epidemiol
. 2002
;31
(4
):839
–46
.24.
Nayak
D
, Nahar
K
, Bhalerao
R
, Kaur
L
, Parveen
T
, Bhalla
R
. Effectiveness of Arsenicum album 30C in prevention of COVID-19 in individuals residing in containment zones of Delhi-A prospective, community-based, parallel cohort study
. Homeopathy
. 2022
. Epub ahead of print.25.
Struyf
T
, Deeks
JJ
, Dinnes
J
, Takwoingi
Y
, Davenport
C
, Leeflang
MMG
. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease [Internet]
. In: Cochrane database of systematic reviews
John Wiley and Sons Ltd
2020
Vol. 2020
[cited 2022 Jan 11]. Available from: 26.
Dixon
BE
, Wools-Kaloustian
K
, Fadel
WF
, Duszynski
TJ
, Yiannoutsos
C
, Halverson
PK
. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: results from a statewide epidemiological study
. medRxiv
. 2020 Oct 22
. Epub ahead of print.27.
World Bank
. Population, total: India | Data [Internet]
2022
[cited 2022 Jan 11]. Available from: https://data.worldbank.org/indicator/SP.POP.TOTL?locations=IN.28.
Tandon
N
, Anjana
RM
, Mohan
V
, Kaur
T
, Afshin
A
, Ong
K
. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990-2016
. Lancet Glob Health
. 2018
;6
(12
):e1352
–62
.29.
Anchala
R
, Kannuri
NK
, Pant
H
, Khan
H
, Franco
OH
, Di Angelantonio
E
. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension
. J Hypertens
. 2014
;32
:1170
–7
.30.
Kamath
S
, Kamath
R
, Salins
P
. COVID-19 pandemic in India: challenges and silver linings
. Postgrad Med J
. 2020
;96
:422
–3
.31.
Press Trust of India
. Homeopathic drug given to half of Gujarat population since March [Internet]
, The Times of Iindia. 2022
[cited 2022 Jan 11]. Available from: https://timesofindia.indiatimes.com/india/homeopathic-drug-given-to-half-of-gujarat-population-since-march/articleshow/77702926.cms.32.
Varma
A
. COVID-19: Kerala Govt distributes homeopathy medicines to 45 lakh people to boost immunity [Internet]
, Republic World. 2022
[cited 2022 Jan 11]. Available from: https://www.republicworld.com/india-news/general-news/covid-19-kerala-govt-distributes-homeopathy-medicines-to-45-lakh-peop.html.33.
Khanna
B
. Citizens rush to homeopathic centres for magic immunity pills [Internet]
, New Indian Express. 2022
[cited 2022 Jan 11]. Available from: https://www.newindianexpress.com/states/karnataka/2020/jun/30/citizens-rush-to-homeopathic-centres-for-magic-immunity-pills-2163139.html.34.
Chakraborty
R
. Homeopathy pills for patients from two Mumbai wards with most cases [Internet]
, The Hindustan Times. 2022
[cited 2022 Jan 11]. Available from: https://www.hindustantimes.com/cities/homeopathy-pills-for-patients-from-two-mumbai-wards-with-most-cases/story-4L0m00P3RGuADPOSNf1IzI.html.35.
Varanasi
R
, Nayak
D
, Kumar
A
, Choubey
G
, Chinta
R
, Oberai
P
. Impact of covid-19 pandemic on patients with non-communicable disease: an observational cross-sectional study at AYUSH set ups of krishna and darjeeling district, India
. Complement Med Res
. 2022
. Epub ahead of print.36.
Daruiche
PSJ
, Canoas
WS
, Figueira
KAG
, Peres
GB
. Homeopathy for COVID-19 prevention: report of an intervention at a Brazilian service sector company
. Homeopathy. 2021 Oct 19
111
2
105
12
.37.
Kestenbaum B. Confounding
Epidemiology and biostatistics
ChamCham
Springer
2019
. p. 125
42
.38.
StrausGlasziou
SP
, Scott
W
, Richardson
WS
, Haynes
RB
Evidence-based medicine: how to practice and teach EBM
5th ed.Philadelphia
Elsevier Churchill Livingstone
2019
. p. 190
.39.
Ministry of AYUSH, Government of India
Guidelines for Homoeopathy practitioners for prophylaxis and symptomatic management of COVID-19 patients in home isolation [Internet]
. 2021
[cited 2022 June 7]. Available from: https://www.ayush.gov.in/docs/CCRH-Revised-Guidelines-for-Homoeopathy-Practitioners-for-Prophylaxis-and-Symptomatic-Management-of-COVID-19-Patients-in-Home-Isolation.pdf.40.
Dewey
W
. Homeopathy in influenza: a chorus of fity in harmony
. J Am Inst Homeopath
13
1038
43
.41.
Mathie
RT
, Baitson
ES
, Frye
J
, Nayak
C
, Manchanda
RK
, Fisher
P
. Homeopathic treatment of patients with influenza-like illness during the 2009 A/H1N1 influenza pandemic in India
. Homeopathy
. 2013 Jul
102
3
187
92
.42.
Nunes
LADS
. Contribution of homeopathy to the control of an outbreak of dengue in Macaé, Rio de Janeiro
. Int J High Dilution Res
. 2008
;7
(25
):186
–92
.43.
Nayak
D
, Nayak
C
, Oberai
P
, Padmanabhan
M
, Singh
H
, Singh
V
. Homoeopathic Genus Epidemicus “Bryonia alba” as a prophylactic during an outbreak of Chikungunya in India: a cluster -randomised, double -blind, placebo- controlled trial
. Indian J Res Homoeopathy
. 2014
;8
(3
):160
.44.
Bracho
G
, Varela
E
, Fernández
R
, Ordaz
B
, Marzoa
N
, Menéndez
J
. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control
. Homeopathy
. 2010 Jul
99
3
156
66
.45.
Indian Council of Medical Research
National guidelines for ethics committees reviewing biomedical & health research during covid-19 pandemic [Internet]
1st edIndian Council of Medical Research
2020
[cited 2021 Jan 11]. Available from: https://ethics.ncdirindia.org//asset/pdf/EC_Guidance_COVID19.pdf.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.
